Trials / Sponsors / CanariaBio Inc.
CanariaBio Inc.
Industry · 5 registered clinical trials.
| Status | Trial | Phase | Started |
|---|---|---|---|
| Active Not Recruiting | Oregovomab Plus Chemotherapy in Neo-adjuvant Setting in Newly Diagnosed Patients With Advanced Epithelial Ovar Ovarian Neoplasm Epithelial, Ovarian Cancer, Fallopian Tube Neoplasms | Phase 2 | 2023-02-07 |
| Active Not Recruiting | A Clinical Study Evaluating a Combination of Oregovomab and Niraparib in Adult Women With Platinum Sensitive R Recurrent Ovarian Cancer, Recurrent Epithelial Cancer of Ovary, Recurrent Epithelial Ovarian Cancer | Phase 2 | 2022-07-25 |
| Active Not Recruiting | Oregovomab in Combination With Bevacizumab Plus Chemo in BRCA Wild Type Platinum Sensitive Recurrent Ovarian C Ovarian Cancer by FIGO Stage, Ovarian Cancer Stage III, Ovarian Cancer Stage IV | Phase 1 / Phase 2 | 2021-03-17 |
| Active Not Recruiting | Oregovomab Plus Chemo in Newly Diagnosed Patients With Advanced Epithelial Ovarian Cancer Following Optimal De Carcinoma, Ovarian Epithelial, Ovarian Neoplasms, Ovarian Cancer | Phase 3 | 2020-08-25 |
| Terminated | The Safety and Antitumor Activity of the Combination of Oregovomab and Hiltonol in Recurrent Advanced Ovarian Cancer of Ovary, Neoplasms, Ovarian, Ovarian Cancer Stage IV | Phase 1 | 2017-05-30 |